Skip to main content

Dermal Fillers Market is Expected to Rise at a CAGR of 7.8% and to Reach USD 6,303.2 Million; Allergan Launches a New Dermal Filler to Expand its Customer Reach: Fortune Business Insights

Written by Customer Service on . Posted in Mergers And Acquisitions.

Pune, Oct. 06, 2020 (GLOBE NEWSWIRE) — The rising demand for minimally-invasive procedures aiding the growth of the global dermal fillers market.  Fortune Business Insights in a new report, titled “DERMAL FILLERS: GLOBAL MARKET ANALYSIS, INSIGHTS AND FORECAST, 2019-2026” suggests that the global market will rise at a CAGR of 7.8% during the forecast period, 2019-2016.The growing awareness about dermal fillers treatment in developed as well as developing countries will help the market reach US$ 6,303.2 Mn by 2026. Furthermore, the global market was worth US$ 3,471.5 Mn in 2018. According to the American Society of Plastic Surgeons (ASPS), over 15.9 million people in the U.S. underwent minimally-invasive cosmetic surgical procedures in the year 2015. The increasing efficiency of dermal fillers is encouraging the next-generation people to invest in these surgeries.Dermal filler procedures help to treat different skin related concerns such as minimizing the appearance of wrinkles and lines. It also adds fullness to areas which have thinned with aging.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/dermal-fillers-market-100939
Key Industry Developments:In April 2019, Merz Pharma announced the launch of its latest dermal filler called the Belotero Revive dermal filler, a combination of hyaluronic acid and glycerolIn April 2019, ALLERGAN announced the launch of Juvéderm VOLUX, a dermal filler aimed at the refinement of the chin and jawlineIn December 2016, Galderma laboratories announced the FDA approval of Restylane Refyne and Restylane Defyne dermal fillers for the treatment of laugh lines
North America Leads Gains Owing to Growing Demand for Advanced Dermal FillersIn 2018, the market in North America was worth US$ 1,596.8 Mn. Driven by the growing demand for innovative and advanced dermal fillers, the region is expected to lead global market through the forecast years. As per a study conducted by ASPS, more than 2 million people in the U.S. underwent hyaluronic acid procedures.Increasing awareness about soft tissue fillers treatment in the U.S. is expected to drive the market in North America. Extensive availability of products in this region is positively impacting the growth of the market.Apart from North America, the market in Asia Pacific is also growing substantially in the forecast years. The rising demand for aesthetics in China and India is creating growth opportunities for the market in Asia Pacific. In addition to this, the awareness about effectiveness of dermal fillers for acne scars, lips, and cheeks is increasing gradually, which is driving the market in this region. Key market leaders in India and China are adopting strategies such as new product launches, augmenting demand for dermal fillers.The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic. We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.
Click here to get the short-term and long-term impact of COVID-19 on this Market.Please visit: https://www.fortunebusinessinsights.com/industry-reports/dermal-fillers-market-100939
Demand for Dermal Fillers to Rise Among Millennials Propelling Growth in the MarketGrowing aging population across the world positively impacts the growth of the market. Increasing number of aged people are undergoing dermal filler therapy to uplift drooping skin and restore lost volume. Continuous support from governments to R&D initiatives and recent regulatory approvals will spur growth in the market.“The dermal fillers market is driven not only by the relative longevity of tissue fillers, but it is also predominantly driven by increasing safety profiles,” said a lead analyst at Fortune Business Insights. “Market players are constantly focusing on innovating and upgrading their product portfolio to ensure accurate and improved aesthetic outcomes for patients,” he added. Driven by continuous innovations and advancements, even millennials find dermal filler treatment appealing. This will further fuel demand for dermal fillers in the forecast period.
Quick Buy –  Dermal Fillers Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/100939
Product Launches by Market Players to Accelerate the Market GrowthALLERGAN was leading the global market in 2018 encompassing a large number of specialized and technologically-advanced products. The company offers a JUVÉDERM collection of dermal fillers, which includes lip enhancement and wrinkles correction. Moreover, the company launched Juvéderm VOLUX to reduce fines lines on jawline and chin.Another company called Merz Pharma recently launched a dermal filler product called Belotero Revive to meet the unique skin requirements of aesthetic patients. Such product launches are expected to help companies broaden their product portfolio, which will stimulate growth in the market.
Key companies covered in the dermal fillers market reportALLERGANMerz PharmaGalderma laboratoriesSinclair PharmaBioPlus Co., Ltd.Bioxis pharmaceuticalsSCULPT Luxury Dermal Fillers LTDDR. KormanProllenium Medical TechnologiesCANDELA CORPORATIONSuneva MedicalAnika Therapeutics, Inc
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/dermal-fillers-market-100939
Global Dermal Fillers Market Segmentation:By Product           •              Biodegradable•              Non-BiodegradableBy Ingredient      •              Hyaluronic Acid•              Calcium Hydroxylapatite•              Poly-L-lactic Acid•              PMMA (Poly (methyl methacrylate))•              Fat Fillers•              OthersBy Application     •              Scar Treatment•              Wrinkle Correction Treatment•              Lip Enhancement•              Restoration of Volume/ Fullness•              OthersBy End User         •              Specialty & Dermatology Clinics•              Hospitals & Clinics•              OthersBy Geography      •              North America (U.S., and Canada)•              Europe (Germany, U.K., France, Italy, Spain, Scandinavia, and Rest of Europe)•              Asia Pacific (China, India, Japan, Australia, South East Asia, and Rest of Asia Pacific)•              Latin America (Brazil, Mexico, and the Rest of Latin America)•              Middle East & Africa (GCC, South Africa, and Rest of Middle East & Africa)
Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/dermal-fillers-market-100939
Have a Look at Related Reports:Digital Radiography Market Share and Global Trend By Product Type (Computed Radiography, Direct Digital Radiography), Application (General, Radiography Dentistry, Oncology, Orthopedic) End User (Hospital, Clinics, Diagnostic Centers) and Geography Forecast till 2026Dialyzers Market Share and Global Trend by Flux Type (High-flux, Low-Flux), By Usage Type (Disposable, Reusable), By End User (Dialysis Centers and Hospitals, Home Healthcare), and Geography Forecast till 2026Breast Cancer Therapeutics Market Share and Global Trend By Therapy (Targeted Therapy, Hormonal Therapy, Chemotherapy), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Cancer Type (Hormone Receptor, HER2+), and Geography Forecast till 2026Hereditary Angioedema Treatment Market Share and Global Trend by Drug Class (C-1 Esterase Inhibitors, Bradykynin Receptor Antagonist, Kallikrein Inhibitors), Application (Prophylaxis, Treatment), Route of Administration (IV, Subcutaneous), Distribution Channel (Hospital Pharmacy, Retail Pharmacy) and Geography Forecast till 2025Active Wound Care Market Share and Global Trend by Product Type (Biological Skin Equivalents, Growth Factors, Biological Dressings), Indication (Diabetic Foot Ulcers, Pressure Ulcers, Lower Limb Ulcers), End User (Hospitals, Clinics, Home Care Settings) and Geography Forecast till 2025
About Us:Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs
Press Release: https://www.fortunebusinessinsights.com/press-release/dermal-fillers-market-9173

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.